Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Cetuximab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Squamous Cell Carcinoma of Head and Neck 20 Carcinoma, Non-Small-Cell Lung 10 Colonic Neoplasms 9 Lung Neoplasms 8 Neoplasm Metastasis 6 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Head and Neck Neoplasms 5 Carcinoma 5 Mouth Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Oropharyngeal Neoplasms 3 Carcinoma, Pancreatic Ductal 3 Solid Tumors 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1

Interventions

pembrolizumab 15 enfortumab vedotin 10 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡